Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7068)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Scaggiante B, Kazemi M, Pozzato G, Dapas B, Farra R, Grassi M, Zanconati F, Grassi G. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol 2014; 20(5): 1268-1288 [PMID: 24574801 DOI: 10.3748/wjg.v20.i5.1268] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i5/1268.htm |
| Number | Citing Articles |
| 1 |
Shasha Wang, Shichao Zhang, Yonggang He, Xiaobing Huang, Yuanjian Hui, Yichen Tang. HOXA11‐AS regulates JAK‐STAT pathway by miR‐15a‐3p/STAT3 axis to promote the growth and metastasis in liver cancer. Journal of Cellular Biochemistry 2019; 120(9): 15941 doi: 10.1002/jcb.28871
|
| 2 |
Nisreen A. A. Osman, Dalia M. Abd El-Rehim, Inas M. Kamal. Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma. Tumor Biology 2015; 36(6): 4293 doi: 10.1007/s13277-015-3068-0
|
| 3 |
Nevine E. EL-Abd, Nahla A. Fawzy, Suzan M. EL-Sheikh, Mohamed E. Soliman. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. Molecular Diagnosis & Therapy 2015; 19(4): 213 doi: 10.1007/s40291-015-0148-1
|
| 4 |
Rossella Farra, Barbara Dapas, Daniele Baiz, Federica Tonon, Sara Chiaretti, Giannino Del Sal, Alessandra Rustighi, Nicola Elvassore, Gabriele Pozzato, Mario Grassi, Gabriele Grassi. Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. Biochimie 2015; 112: 85 doi: 10.1016/j.biochi.2015.02.015
|
| 5 |
Qingqiang Shi, Xueping Shi, Gei Zuo, Wei Xiong, Haixing Li, Pei Guo, Fen Wang, Yi Chen, Jing Li, Di-Long Chen. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin. Oncology Reports 2016; 36(4): 2059 doi: 10.3892/or.2016.5033
|
| 6 |
Qingquan Liu, Kangsheng Tu, Hongyong Zhang, Xin Zheng, Yingmin Yao, Qingguang Liu. TPX2 as a novel prognostic biomarker for hepatocellular carcinoma. Hepatology Research 2015; 45(8): 906 doi: 10.1111/hepr.12428
|
| 7 |
Zhi-Ming Zhang, Yu-Mei Zhang, Sheng Gao, Wei-Ping Yuan, Yin-Nong Zhao, Bang-De Xiang, Fei-Xiang Wu, Guo-Bin Wu, Jian-Yong Liu. Treatment Efficacy and Prognostic Factors for Huge HCC Based on Barcelona Clinic Liver Cancer Staging. Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8823 doi: 10.7314/APJCP.2014.15.20.8823
|
| 8 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 9 |
G. Cavallaro, M. Licciardi, G. Amato, C. Sardo, G. Giammona, R. Farra, B. Dapas, M. Grassi, G. Grassi. Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery. International Journal of Pharmaceutics 2014; 466(1-2): 246 doi: 10.1016/j.ijpharm.2014.03.026
|
| 10 |
Rossella Farra, Mario Grassi, Gabriele Grassi, Barbara Dapas. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(30): 8994-9001 doi: 10.3748/wjg.v21.i30.8994
|
| 11 |
ZHEN YANG, SUN YANG, BOBBYE J. MISNER, FENG LIU-SMITH, FRANK L. MEYSKENS. The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression. International Journal of Oncology 2014; 45(5): 1820 doi: 10.3892/ijo.2014.2589
|
| 12 |
Jianning Song, Hongzhong Zhou, Dayong Gu, Yong Xu. Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.790358
|
| 13 |
Faryal Mehwish Awan, Anam Naz, Ayesha Obaid, Amjad Ali, Jamil Ahmad, Sadia Anjum, Hussnain Ahmed Janjua, Alessandro Weisz. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach. PLOS ONE 2015; 10(9): e0138913 doi: 10.1371/journal.pone.0138913
|
| 14 |
Urvashi Vijay, Pranathi Pappu, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 293 doi: 10.1016/B978-0-323-98806-3.00008-8
|
| 15 |
David E. Amacher. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 2016; 21(5): 387 doi: 10.3109/1354750X.2016.1153724
|
| 16 |
Shimaa Abdelsattar, Dina Sweed, Hala F. M. Kamel, Zeinab A. Kasemy, Abdallah M. Gameel, Hassan Elzohry, Omnia Ameen, Eman Ibrahim Elgizawy, Ahmed Sallam, Asmaa Mosbeh, Mahmoud S. Abdallah, Fatma O. Khalil, Hiba S. Al-Amodi, Sally M. El-Hefnway. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. Biomolecules 2022; 13(1): 3 doi: 10.3390/biom13010003
|
| 17 |
Zhengchen Jiang, Bowen Shi, Yun Zhang, Tianming Yu, Yang Cheng, Jiankang Zhu, Guangyong Zhang, Mingwei Zhong, Sanyuan Hu, Xiaomin Ma. CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway. iScience 2024; 27(2): 108843 doi: 10.1016/j.isci.2024.108843
|
| 18 |
Magdalena Görtz, Uwe Galli, Thomas Longerich, Margot Zöller, Ulrike Erb, Peter Schemmer. De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells. Oncology Reports 2017; 38(5): 2697 doi: 10.3892/or.2017.5980
|
| 19 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular Biology Reports 2020; 47(10): 7429 doi: 10.1007/s11033-020-05798-5
|
| 20 |
Shyh‐Horng Chiou, King‐Teh Lee. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco‐proteogenomics approach. The Kaohsiung Journal of Medical Sciences 2016; 32(11): 535 doi: 10.1016/j.kjms.2016.09.002
|
| 21 |
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9
|
| 22 |
QINGQIANG SHI, JING LI, ZIQIANG FENG, LVCUI ZHAO, LIAN LUO, ZHIMEI YOU, DANYANG LI, JING XIA, GUOWEI ZUO, DILONG CHEN. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Molecular Medicine Reports 2014; 10(4): 1779 doi: 10.3892/mmr.2014.2392
|
| 23 |
Rongliang Tong, Beng Yang, Heng Xiao, Chuanhui Peng, Wendi Hu, Xiaoyu Weng, Shaobing Cheng, Chengli Du, Zhen Lv, Chaofeng Ding, Lin Zhou, Haiyang Xie, Jian Wu, Shusen Zheng. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. Oncotarget 2017; 8(23): 37717 doi: 10.18632/oncotarget.17145
|
| 24 |
Soon Sun Kim, Hyo Jung Cho, Je Hwan Won, Jae Ik Bae, Dae Ryong Kang, Jung-Dong Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Jai Keun Kim, Jei Hee Lee, Seon Joo Ahn, Ju Han Park, Sung Won Cho, Jae Youn Cheong. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. Cytokine 2015; 76(2): 449 doi: 10.1016/j.cyto.2015.07.001
|
| 25 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Mauro Podda, Jane Warwick, Ramesh Arasaradnam. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines 2020; 8(2): 247 doi: 10.3390/vaccines8020247
|
| 26 |
Yan-Zhou Song, Xu Li, Wei Li, Zhong Wang, Kai Li, Fang-Liang Xie, Feng Zhang. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas. World Journal of Gastroenterology 2018; 24(28): 3145-3154 doi: 10.3748/wjg.v24.i28.3145
|
| 27 |
Jaleh Varshosaz, Maryam Farzan. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12022-12041 doi: 10.3748/wjg.v21.i42.12022
|
| 28 |
Zerui Song, Chuyi Song, Jiazhi Song, Jingqing Jiang. Prediction of Protein-ATP Binding Sites Based on Word Vector Convolution Model. Proceedings of the 2022 5th International Conference on Algorithms, Computing and Artificial Intelligence 2022; : 1 doi: 10.1145/3579654.3579660
|
| 29 |
Xiaoyu Yang, Yunhong Xia, Shuomin Wang, Chen Sun, Raj Kumar Koiri. Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 2022; 17(8): e0273317 doi: 10.1371/journal.pone.0273317
|
| 30 |
Peng Xiu, Xiao-Feng Dong, Xin-Ping Li, Jie Li. Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(27): 8262-8270 doi: 10.3748/wjg.v21.i27.8262
|
| 31 |
Gennara Cavallaro, Rossella Farra, Emanuela Fabiola Craparo, Carla Sardo, Barbara Porsio, Gaetano Giammona, Francesca Perrone, Mario Grassi, Gabriele Pozzato, Gabriele Grassi, Barbara Dapas. Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells. International Journal of Pharmaceutics 2017; 525(2): 397 doi: 10.1016/j.ijpharm.2017.01.034
|
| 32 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, Mahdi Paryan. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma. Tumor Biology 2017; 39(4): 101042831769836 doi: 10.1177/1010428317698361
|
| 33 |
Bruna Scaggiante, Rosella Farra, Barbara Dapas, Gabriele Baj, Gabriele Pozzato, Mario Grassi, Fabrizio Zanconati, Gabriele Grassi. Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects. International Journal of Pharmaceutics 2016; 506(1-2): 268 doi: 10.1016/j.ijpharm.2016.04.031
|
| 34 |
Steven Alexander Mann, Romil Saxena. Predictive Biomarkers in Oncology. 2019; : 437 doi: 10.1007/978-3-319-95228-4_40
|
| 35 |
N. Halib, M.C.I. Mohd Amin, I. Ahmad, M. Abrami, S. Fiorentino, R. Farra, G. Grassi, F. Musiani, R. Lapasin, M. Grassi. Topological characterization of a bacterial cellulose–acrylic acid polymeric matrix. European Journal of Pharmaceutical Sciences 2014; 62: 326 doi: 10.1016/j.ejps.2014.06.004
|
| 36 |
Aimei Liu, Qinghua Wu, Dapeng Peng, Irma Ares, Arturo Anadón, Bernardo Lopez‐Torres, María‐Rosa Martínez‐Larrañaga, Xu Wang, María‐Aránzazu Martínez. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Medicinal Research Reviews 2020; 40(5): 1973 doi: 10.1002/med.21696
|
| 37 |
Qing-Qiang Shi, Guo-Wei Zuo, Zi-Qiang Feng, Lv-Cui Zhao, Lian Luo, Zhi-Mei You, Dang-Yang Li, Jing Xia, Jing Li, Di-Long Chen. Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7849 doi: 10.7314/APJCP.2014.15.18.7849
|
| 38 |
Verónica del Carmen Martínez‐Jiménez, Alejandro Méndez‐Mancilla, Diana Patricia Portales‐Pérez. miRNAs in nutrition, obesity, and cancer: The biology of miRNAs in metabolic disorders and its relationship with cancer development. Molecular Nutrition & Food Research 2018; 62(1) doi: 10.1002/mnfr.201600994
|
| 39 |
Yi-Gang Wang, Pan-Pan Huang, Rong Zhang, Bu-Yun Ma, Xiu-Mei Zhou, Yan-Fang Sun. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 326-337 doi: 10.3748/wjg.v22.i1.326
|
| 40 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 41 |
Medhat S. El-Halawany, Heba M. Ismail, Ahmed A. Zeeneldin, Ammar Elfiky, Marwa Tantawy, Mohamed H. Kobaisi, Ikram Hamed, Abdel Hady A. Abdel Wahab. Investigating the Pretreatment miRNA Expression Patterns of Advanced Hepatocellular Carcinoma Patients in Association with Response to TACE Treatment. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/649750
|
| 42 |
Santosh K. Misra, Tania Ray, Fatemeh Ostadhossein, Bomy Kim, Partha S. Ray, Dipanjan Pan. Carotenoid Nanovector for Efficient Therapeutic Gene Knockdown of Transcription Factor FOXC1 in Liver Cancer. Bioconjugate Chemistry 2016; 27(3): 594 doi: 10.1021/acs.bioconjchem.5b00601
|
| 43 |
Yongfeng Hui, Dong Jin, Junzhi Leng, Di Liu, Peng Yuan, Chaofeng Tang, Qi Wang. Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway. Pathology - Research and Practice 2022; 229: 153692 doi: 10.1016/j.prp.2021.153692
|
| 44 |
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly. Novel biomarkers in hepatocellular carcinoma. Digestive and Liver Disease 2018; 50(11): 1115 doi: 10.1016/j.dld.2018.08.019
|
| 45 |
C. Toso, V. Mazzaferro, J. Bruix, R. Freeman, G. Mentha, P. Majno. Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma. American Journal of Transplantation 2014; 14(10): 2221 doi: 10.1111/ajt.12923
|
| 46 |
Dan‑Hong Huang, Jie Jian, Shuang Li, Yan Zhang, Li‑Zhen Liu. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4371
|
| 47 |
Lorenza Rimassa, Maria Reig, Giovanni Abbadessa, Markus Peck-Radosavljevic, William Harris, Vittorina Zagonel, Davide Pastorelli, Elena Rota Caremoli, Camillo Porta, Nevena Damjanov, Hitendra Patel, Bruno Daniele, Maria Lamar, Brian Schwartz, Terri Goldberg, Armando Santoro, Jordi Bruix. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(13): 2448-2452 doi: 10.3748/wjg.v23.i13.2448
|
| 48 |
Yu-Cheng Zhang, Zhuo Xu, Tian-Fu Zhang, Ya-Li Wang. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(34): 9853-9862 doi: 10.3748/wjg.v21.i34.9853
|
| 49 |
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Shuji Terai. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers 2019; 11(12): 1865 doi: 10.3390/cancers11121865
|
| 50 |
J Huang, J Yang, Y Lei, H Gao, T Wei, L Luo, F Zhang, H Chen, Q Zeng, L Guo. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma. Oncogenesis 2016; 5(5): e229 doi: 10.1038/oncsis.2016.22
|
| 51 |
Jingyu Zhang, Jingmin Li, Haoran Song, Yanlian Xiong, Desheng Liu, Xianyong Bai. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation. Biomedicine & Pharmacotherapy 2019; 109: 806 doi: 10.1016/j.biopha.2018.09.086
|
| 52 |
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomedicine & Pharmacotherapy 2018; 97: 339 doi: 10.1016/j.biopha.2017.07.168
|
| 53 |
Lucia Scarabel, Francesca Perrone, Marica Garziera, Rossella Farra, Mario Grassi, Francesco Musiani, Concetta Russo Spena, Barbara Salis, Lucia De Stefano, Giuseppe Toffoli, Flavio Rizzolio, Federica Tonon, Michela Abrami, Gianluca Chiarappa, Gabriele Pozzato, Giancarlo Forte, Gabriele Grassi, Barbara Dapas. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells. Expert Opinion on Drug Delivery 2017; 14(6): 797 doi: 10.1080/17425247.2017.1292247
|
| 54 |
Cheng-Wei Li, Ping-Yao Chang, Bor-Sen Chen. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget 2016; 7(48): 79453 doi: 10.18632/oncotarget.13100
|
| 55 |
Meng Xu, Qingquan Liu, Yuli Jia, Kangsheng Tu, Yingmin Yao, Qingguang Liu, Cheng Guo. BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma. Oncology Letters 2016; 12(4): 2648 doi: 10.3892/ol.2016.4969
|
| 56 |
Zeinab Ahsani, Samira Mohammadi-Yeganeh, Vahid Kia, Hamzeh Karimkhanloo, Nosratollah Zarghami, Mahdi Paryan. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2017; 181(3): 884 doi: 10.1007/s12010-016-2256-8
|